Fundación Dr. Mario Socolinsky - Centro de Vacunación Proteger

Ciudad Autónoma de BuenosAires C1023

0 studies enrolling now · 1 studies all time

What they study most

Respiratory Syncytial Virus

Studies at this site

• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed